Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 30.01%
March 31, 2026 27.56%
December 31, 2025 28.89%
September 30, 2025 28.52%
June 30, 2025 29.45%
March 31, 2025 26.76%
December 31, 2024 28.91%
September 30, 2024 26.26%
June 30, 2024 27.86%
March 31, 2024 24.43%
December 31, 2023 27.99%
September 30, 2023 27.58%
June 30, 2023 26.33%
March 31, 2023 28.18%
December 31, 2022 33.99%
September 30, 2022 36.68%
June 30, 2022 38.10%
March 31, 2022 42.59%
December 31, 2021 38.79%
September 30, 2021 42.03%
June 30, 2021 39.89%
March 31, 2021 34.61%
December 31, 2020 36.76%
September 30, 2020 34.75%
June 30, 2020 28.23%
Date Value
March 31, 2020 27.98%
December 31, 2019 30.10%
September 30, 2019 30.72%
June 30, 2019 31.35%
March 31, 2019 31.67%
December 31, 2018 33.86%
September 30, 2018 33.92%
June 30, 2018 34.96%
March 31, 2018 32.76%
December 31, 2017 35.40%
September 30, 2017 37.07%
June 30, 2017 38.78%
March 31, 2017 36.69%
December 31, 2016 37.96%
September 30, 2016 38.07%
June 30, 2016 38.18%
March 31, 2016 35.60%
December 31, 2015 36.70%
September 30, 2015 37.75%
June 30, 2015 36.72%
March 31, 2015 36.00%
December 31, 2014 37.34%
September 30, 2014 38.14%
June 30, 2014 37.72%
March 31, 2014 37.78%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
BML, Inc. 33.53%
Quest Diagnostics, Inc. 32.53%
Labcorp Holdings, Inc. 27.71%
OPKO Health, Inc. 37.32%
Psychemedics Corp. --